Keywords: Daiichi Sankyo, Flu vaccine, Supply problem, Silodosin, China

Daiichi Sankyo admits supply problem with flu vaccine; gains approval for silodosin in China

Article | 23 September 2011

Japanese drug major Daiichi Sankyo (TYO: 4568) announced this week that its domestic subsidiary, Kitasato Daiichi Sankyo Vaccine, will be unable ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Daiichi Sankyo

Go to company listing

Related Drugs

silodosin

Go to drug listing